| Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas (NCT04623931) | M.D. Anderson Cancer Center | 2020-01-30 |
| Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma (NCT03180502) | NRG Oncology | 2018-01-23 |
| Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children (NCT03043391) | Istari Oncology, Inc. | 2017-11-07 |
| Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma (NCT03072134) | Northwestern University | 2017-04-24 |
| Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas (NCT02795364) | Huashan Hospital | 2016-06-01 |
| A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme (NCT05600491) | Sun Yat-sen University | 2015-11-08 |
| A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma (NCT02026271) | Alaunos Therapeutics | 2015-06-01 |
| Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas (NCT02015819) | City of Hope Medical Center | 2014-10-07 |
| Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma (NCT02168270) | University of Nebraska | 2014-06-16 |
| Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor (NCT01985256) | Tocagen Inc. | 2014-02-01 |
| Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas (NCT01849952) | Dartmouth-Hitchcock Medical Center | 2013-10-09 |
| Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas (NCT01922076) | National Cancer Institute (NCI) | 2013-09-03 |
| Re-irradiation of High Grade Gliomas: a Quality of Life Study (NCT01711580) | Maastricht Radiation Oncology | 2013-03-01 |
| Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas (NCT01721577) | Rush University Medical Center | 2012-12-01 |
| Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma (NCT01250470) | Roswell Park Cancer Institute | 2012-09-05 |
| A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas (NCT01765088) | Sun Yat-sen University | 2012-09-01 |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma (NCT01656980) | Shandong Lanjin Pharmaceuticals Co.,Ltd | 2012-08-01 |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma (NCT01637753) | Shandong Lanjin Pharmaceuticals Co.,Ltd | 2012-06-01 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor (NCT01470794) | Tocagen Inc. | 2012-02-01 |
| Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (NCT01189266) | National Cancer Institute (NCI) | 2010-08-09 |
| A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma (NCT01156584) | Tocagen Inc. | 2010-07-01 |
| Sorafenib in Newly Diagnosed High Grade Glioma (NCT00884416) | University Hospital, Geneva | 2009-03-01 |
| Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors (NCT00303849) | OHSU Knight Cancer Institute | 2005-09-15 |
| Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols (NCT00035373) | National Cancer Institute (NCI) | 2002-04-19 |